About Panacea Biotec Pharma Limited
Data last updated:
Panacea Biotec Pharma Limited is a public limited company based in New, Delhi, India, a subsidiary of Panacea Biotec Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2019PLC347566. Its GSTIN is 07AAKCP4431B1ZQ (Delhi). The company holds 22 GST registrations, of which 21 are active.
The company has an authorised share capital of ₹60 Cr and a paid-up capital of ₹10 Lakh. It is led by directors including Rajesh Jain (Managing Director) and Ankesh Jain (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 1 Extension/A – 27 Mohan Co – Operative Industrial Estate Mathura Road, New, Delhi, India – 110044.
As per the financials filed for FY 2025, the company reported a revenue of ₹265.23 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹16.94 Cr (net margin 6.4%) and EBITDA of ₹37.16 Cr (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 37% over five years.
The company has about 749 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Panacea Biotec. As per MCA filings, the company has satisfied charges of ₹1,618.44 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.
For more details, the company can be reached via its website panaceabiotec.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressB – 1 Extension/A – 27 Mohan Co – Operative Industrial Estate Mathura Road, New, Delhi, India – 110044
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Panacea Biotec Pharma Limited
Panacea Biotec Pharma has one previous CIN (Corporate Identification Number): U24299PB2019PLC068319. The current CIN is U24299DL2019PLC347566, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24299DL2019PLC347566 | Current |
| U24299PB2019PLC068319 | Previous |
Associated Brands with Panacea Biotec Pharma Limited
Panacea Biotec Pharma operates one associated brand: Panacea Biotec. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of biosimilars, vaccines and natural products | panaceabiotec.com |
Competitors & Alternatives of Panacea Biotec Pharma Limited
Brands and companies operating in the same space as Panacea Biotec Pharma Limited include Abzena, Syngene, Grand River Aseptic Manufacturing and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Abzena | Provider of antibody discovery, cell line development, and bio analytics services | Cambridge, United Kingdom | 2001 |
 Syngene | Provider of contract research and manufacturing services for both small molecules and biologics | Bengaluru, India | 1993 |
 Grand River Aseptic Manufacturing | Sterile parenteral CDMO services for development and manufacturing are offered. | Grand Rapids, United States | 2010 |
 Patheon | Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | Durham, United States | 1974 |
 Piramal Group | Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | Mumbai, India | 1984 |
 Maravai Life Sciences | Provides enabling tools and services in the life sciences research and bio-production industries | San Diego, United States | 2014 |
 LakePharma | Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | Belmont, United States | 2009 |
 Insud Pharma | Finished formulations, APIs, and monoclonal antibodies are developed and manufactured. | Madrid, Spain | 1977 |
Business Activity of Panacea Biotec Pharma Limited
The main business activity of Panacea Biotec Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Panacea Biotec Pharma Limited
Panacea Biotec Pharma Limited is audited by Walker Chandiok & Co LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Walker Chandiok & Co LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Panacea Biotec Pharma Limited
Panacea Biotec Pharma has 6 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankesh Jain Also directs: Panacea Biotec Limited, Adveta Power Private Limited | Whole-Time Director | 22 Mar 2019 | 7 Years 6 Months | Current |
| Rajesh Jain Also directs: Panacea Biotec Limited, Sundrop Brands Limited, Federal-Mogul Goetze (India) Limited and 3 more | Director | 12 Nov 2024 | 1 Years 10 Months | Current |
| Manjula Upadhyay | Director | 23 Jul 2021 | 5 Years 2 Months | Current |
| Narotam Kumar Juneja | Whole-Time Director | 01 Apr 2022 | 4 Years 6 Months | Current |
| Rajesh Jain | Managing Director | 22 Mar 2019 | 7 Years 6 Months | Current |
| Sanjay Trehan Also directs: Panacea Biotec Limited | Whole-Time Director | 13 Feb 2025 | 1 Years 7 Months | Current |
Financials of Panacea Biotec Pharma Limited FY 2025 filings available
Panacea Biotec Pharma Limited reported revenue of ₹265.23 Cr (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Panacea Biotec Pharma Limited
Revenue has grown at a compounded annual rate (CAGR) of 37% over five years, including 26% growth in the latest year. EBITDA rose 201% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Panacea Biotec Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹37.16 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹16.94 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Panacea Biotec Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Panacea Biotec Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Panacea Biotec Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Panacea Biotec Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2020 | Others | ₹754.44 Cr | Satisfied |
| 06 Apr 2019 | Others | ₹864 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Panacea Biotec Pharma Limited
Panacea Biotec Pharma Limited has a workforce of 749 employees as of Mar 25, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Panacea Biotec Pharma Limited
Panacea Biotec Pharma has 22 GST registrations: 21 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCP4431B1ZQ | Delhi | Active | 16 Apr 2019 |
| 07AAKCP4431B2ZP | Delhi | Active | 04 Jul 2020 |
| 18AAKCP4431B1ZN | Assam | Active | 13 Aug 2019 |
| 24AAKCP4431B1ZU | Gujarat | Active | 14 Aug 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Panacea Biotec Pharma Limited
Panacea Biotec Pharma Limited has 4 court cases on record: 1 filed by Panacea Biotec Pharma, 1 filed against it, 2 where it is another party. 1 case is pending and 3 are disposed. Status as checked between 21 Sep 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
| District courts | 2 | 1 | 1 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Execution petition | Filed against the company by an individual | Pending |
| High Court of Punjab and Haryana | Writ petition | Company is another party | Disposed |
| District court, New Delhi, Delhi | Criminal case | Filed by the company against Manora Ghukul Enterprises | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Panacea Biotec Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Panacea Biotec Pharma Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Panacea Biotec Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Panacea Biotec Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Panacea Biotec Pharma Limited
Recent News on Panacea Biotec Pharma Limited
Frequently Asked Questions about Panacea Biotec Pharma Limited
Panacea Biotec Pharma is an active public limited company based in New, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 March 2019 (7+ years old) and is registered under CIN U24299DL2019PLC347566.
Panacea Biotec Pharma reported revenue of ₹265.23 Cr for FY 2025 (up 26% YoY).
Panacea Biotec Pharma has 6 current directors:
- Rajesh Jain - Managing Director
- Ankesh Jain - Whole-Time Director
- Narotam Kumar Juneja - Whole-Time Director
- Sanjay Trehan - Whole-Time Director
- Rajesh Jain - Director
- Manjula Upadhyay - Director
Panacea Biotec Pharma reported a net profit of ₹16.94 Cr (net margin 6.4%) and EBITDA of ₹37.16 Cr (EBITDA margin 14%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Panacea Biotec Pharma is -13% over three years and 37% over five years. In the latest year (FY 2025) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Panacea Biotec Pharma is 07AAKCP4431B1ZQ, registered in Delhi. The company has 22 GST registrations in all, of which 21 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAKCP4431B2ZP (Delhi), 18AAKCP4431B1ZN (Assam), 24AAKCP4431B1ZU (Gujarat).
The CIN (Corporate Identification Number) of Panacea Biotec Pharma is U24299DL2019PLC347566. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Panacea Biotec Pharma has 4 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Panacea Biotec Pharma was incorporated on 22 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.